Use of radiation with or without WR-2721 in advanced rectal cancer

Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.

1980 • 300 citations

Differential Chemoprotection of Normal and Malignant Tissues<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1969 • 266 citations

Alkaline Phosphatase Promotes Radioprotection and Accumulation of WR-1065 in V79-171 Cells Incubated in Medium Containing WR-2721

1985 • 168 citations

Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.

1988 • 145 citations

Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.

1988 • 119 citations

The modification of melphalan toxicity in tumor bearing mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR2721)

1982 • 74 citations

Prediction of the Effective Radioprotective Dose of WR-2721 in Humans through an Interspecies Tissue Distribution Study

1976 • 68 citations

Interim analysis of a randomized trial of radiation therapy of rectal cancer with/without WR-2721

1992 • 51 citations

Misonidazole enhancement of acute and late radiation injury to the rat spinal cord

1979 • 22 citations

Cited By (0)

Loading...